USP

home / authors / usp-2

Articles

USP Biologics

USP offers a growing portfolio of well characterized monoclonal antibody (mAb) reference standards and associated characterization data.

COVID-19's Impact: Help Ensure Quality and Manage Risk

October 21st 2020

COVID-19’s Impact: Help Ensure Quality and Manage Risk

COVID-19’s Impact: Help Ensure Quality and Manage Risk

October 19th 2020

Dissolution and the USP Performance Verification Test

January 23rd 2019

Risk Assessments and Sourcing Strategies for Excipients and APIs

January 2nd 2018

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: August 21st 2024 | Updated: December 26th 2024

Pharmaceutical Technology Editorial Advisory Board

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Published: November 25th 2024 | Updated: December 26th 2024

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Published: December 20th 2024 | Updated: December 26th 2024

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Europa Perspectives: Helping to Navigate the Regulatory System

Published: February 23rd 2024 | Updated: December 26th 2024

Europa Perspectives: Helping to Navigate the Regulatory System

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.